| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | Director | Aug 15, 2025 | Option/RSU Exercise | - | 724 | - | 10,826 | Aug 19, 2025, 04:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | Director | Aug 18, 2025 | Sale | $16.65 | 217 | 3,613 | 10,609 | Aug 19, 2025, 04:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | May 16, 2025 | Sale | $7.28 | 220 | 1,602 | 10,102 | May 19, 2025, 04:05 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | May 15, 2025 | Option/RSU Exercise | - | 721 | - | 10,322 | May 19, 2025, 04:05 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Feb 15, 2025 | Option/RSU Exercise | - | 34,376 | - | 204,765 | Feb 19, 2025, 08:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Feb 18, 2025 | Sale | $0.81 | 12,726 | 10,314 | 192,039 | Feb 19, 2025, 08:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Nov 15, 2024 | Option/RSU Exercise | - | 7,812 | - | 172,894 | Nov 19, 2024, 04:15 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Nov 18, 2024 | Sale | $0.54 | 2,505 | 1,355 | 170,389 | Nov 19, 2024, 04:15 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Oct 27, 2024 | Option/RSU Exercise | - | 27,837 | - | 173,830 | Oct 29, 2024, 06:24 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Oct 28, 2024 | Sale | $0.69 | 8,748 | 6,037 | 165,082 | Oct 29, 2024, 06:24 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Aug 15, 2024 | Option/RSU Exercise | - | 7,813 | - | 148,511 | Aug 19, 2024, 05:38 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Aug 16, 2024 | Sale | $0.84 | 2,518 | 2,115 | 145,993 | Aug 19, 2024, 05:38 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | May 15, 2024 | Option/RSU Exercise | - | 7,812 | - | 143,133 | May 17, 2024, 08:18 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | May 15, 2024 | Sale | $0.94 | 2,435 | 2,289 | 140,698 | May 17, 2024, 08:18 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Feb 15, 2024 | Option/RSU Exercise | - | 31,250 | - | 146,870 | Feb 16, 2024, 09:42 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Feb 16, 2024 | Sale | $1.08 | 11,549 | 12,473 | 135,321 | Feb 16, 2024, 09:42 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Oct 27, 2023 | Option/RSU Exercise | - | 27,838 | - | 124,172 | Oct 31, 2023, 09:40 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Oct 30, 2023 | Sale | $1.35 | 8,552 | 11,545 | 115,620 | Oct 31, 2023, 09:40 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Jul 05, 2022 | Award/Grant | $3.15 | 63,492 | 200,000 | 96,334 | Jul 06, 2022, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CEO and President | Jan 26, 2020 | Option/RSU Exercise | - | 20,000 | - | 32,842 | Jan 28, 2020, 04:07 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | See Remarks | Jan 26, 2019 | Option/RSU Exercise | - | 12,000 | - | 17,220 | Jan 29, 2019, 06:52 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | See Remarks | Jan 28, 2019 | Sale | $5.75 | 4,378 | 25,188 | 12,842 | Jan 29, 2019, 06:52 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | See Remarks | Jan 26, 2018 | Option/RSU Exercise | - | 8,000 | - | 8,000 | Jan 30, 2018, 09:01 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | See Remarks | Jan 26, 2018 | Sale | $11.02 | 2,780 | 30,636 | 5,220 | Jan 30, 2018, 09:01 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 30, 2016 | Option/RSU Exercise | $7.79 | 4,533 | 35,312 | 4,533 | Jun 30, 2016, 05:46 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 30, 2016 | Sale | $29.54 | 4,533 | 133,905 | 0 | Jun 30, 2016, 05:46 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 27, 2016 | Option/RSU Exercise | $7.79 | 3,334 | 25,972 | 3,334 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 27, 2016 | Sale | $28.00 | 3,334 | 93,352 | 0 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 28, 2016 | Option/RSU Exercise | $7.79 | 1,667 | 12,986 | 1,667 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Jun 28, 2016 | Sale | $28.85 | 1,667 | 48,093 | 0 | Jun 29, 2016, 07:21 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Apr 04, 2016 | Option/RSU Exercise | $7.79 | 6,568 | 51,165 | 6,568 | Apr 06, 2016, 05:44 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Apr 04, 2016 | Sale | $28.85 | 6,568 | 189,487 | 0 | Apr 06, 2016, 05:44 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Mar 31, 2016 | Option/RSU Exercise | $7.79 | 7,663 | 59,695 | 7,663 | Apr 04, 2016, 07:23 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Mar 31, 2016 | Sale | $26.30 | 7,663 | 201,569 | 6,568 | Apr 04, 2016, 07:23 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Mar 28, 2016 | Sale | $24.07 | 5,473 | 131,735 | 0 | Mar 29, 2016, 07:08 PM | |
| MCRB | Seres Therapeutics, Inc. | Eric D. Shaff | CFO and EVP | Mar 28, 2016 | Option/RSU Exercise | $7.79 | 5,473 | 42,635 | 5,473 | Mar 29, 2016, 07:08 PM |